Lin Hsuan-Jen, Lin Chung-Chih, Lin Hsuan Ming, Chen Hsuan-Ju, Lin Che-Chen, Chang Chiz-Tzung, Chou Che-Yi, Huang Chiu-Ching
Division of Nephrology, Department of Internal Medicine, Asia University Hospital, Wufeng, Taichung, Taiwan.
Kidney Institute and Division of Nephrology, Department of Internal Medicine, China Medical University Hospital, Wufeng, Taichung, Taiwan.
Nephrology (Carlton). 2018 Jun;23(6):559-564. doi: 10.1111/nep.13049.
The prevalence of hypothyroidism is high in haemodialysis (HD) patients and hypothyroidism increases all-cause mortality in HD patients. Comorbidities are common in HD patients and are associated with both mortality and hypothyroidism. The aim of the study is to explore the effect of the interactions of comorbidities and hypothyroidism on all-cause mortality in HD patients.
Patients with hypothyroidism (ICD-9-CM 244.0, 244.1, and 244.9) and matched patients without hypothyroidism in the Registry for Catastrophic Illness Patient Database of Taiwan Health Insurance from 2000 to 2010 were analyzed. The association of hypothyroidism and risk of all-cause mortality was analyzed using Cox proportional hazard regression.
Nine hundred and eight HD patients with hypothyroidism and 3632 sex-, age-, gender- matched HD patients without hypothyroidism were analyzed. Hypothyroidism was associated with increased all-cause mortality with an adjusted hazard ratio of 1.22 [95% confidence interval (CI): 1.10-1.36, P < 0.001]. TRT may decrease mortality associated with hypothyroidism (P < 0.001). There was a significant interaction (P = 0.04) between diabetes and hypothyroidism. There was no significant interaction found in hypothyroidism and the following comorbidities: hyperlipidaemia, hypertension, chronic obstructive pulmonary disease, coronary artery disease, stroke, peripheral arterial disease, asthma, congestive heart failure and cancer.
Hypothyroidism is associated with increased all-cause mortality in chronic HD patients. The interaction of hypothyroidism and diabetes, but not other common comorbidities in HD patients, has an effect on mortality risks.
甲状腺功能减退症在血液透析(HD)患者中患病率较高,且甲状腺功能减退会增加HD患者的全因死亡率。合并症在HD患者中很常见,且与死亡率和甲状腺功能减退症均相关。本研究旨在探讨合并症与甲状腺功能减退症的相互作用对HD患者全因死亡率的影响。
分析了2000年至2010年台湾健康保险重大伤病患者数据库中患有甲状腺功能减退症(国际疾病分类第九版临床修订本代码244.0、244.1和244.9)的患者以及匹配的无甲状腺功能减退症的患者。使用Cox比例风险回归分析甲状腺功能减退症与全因死亡风险之间的关联。
分析了908例患有甲状腺功能减退症的HD患者和3632例性别、年龄、性别匹配的无甲状腺功能减退症的HD患者。甲状腺功能减退症与全因死亡率增加相关,校正后的风险比为1.22[95%置信区间(CI):1.10-1.36,P<0.001]。甲状腺激素替代治疗(TRT)可能会降低与甲状腺功能减退症相关的死亡率(P<0.001)。糖尿病与甲状腺功能减退症之间存在显著的相互作用(P=0.04)。在甲状腺功能减退症与以下合并症之间未发现显著的相互作用:高脂血症、高血压、慢性阻塞性肺疾病、冠状动脉疾病、中风、外周动脉疾病、哮喘、充血性心力衰竭和癌症。
甲状腺功能减退症与慢性HD患者的全因死亡率增加相关。甲状腺功能减退症与糖尿病之间的相互作用,而非HD患者的其他常见合并症,对死亡风险有影响。